CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist
  • 25.19
  • +0.23+0.92%
Noon Break Mar 18 11:29 CST
67.29BMarket Cap31.85P/E (TTM)

Shanghai Fosun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Fosun Pharmaceutical Q4 2024 Estimates Date

Currency：CNYMar 25, 2025

Estimate YoY
Revenue
11.18B
+5.95%
EPS
0.26
+537.50%
Analyst Rating
Strong Buy

Mar 18, 2025

Shanghai Fosun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.286B--
Mar 25, 20252024/Q4-- / 11.176B--
Oct 29, 20242024/Q310.449B / 10.338B--
Aug 27, 20242024/Q210.226B / 10.561B--
Apr 29, 20242024/Q110.157B / 10.691B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.286B--
Mar 25, 20252024/Q4-- / 11.176B--
Oct 29, 20242024/Q310.449B / 10.338B--
Aug 27, 20242024/Q210.226B / 10.561B--
Apr 29, 20242024/Q110.157B / 10.691B--

Unlock Free Earnings Estimates

Shanghai Fosun Pharmaceutical Earnings Reports

  • Fosun Pharmaceuticals 2024 Third Quarter Report

    Oct 29, 2024 12:00 ET

  • Fosun Pharmaceutical 2024 Semi-Annual Report

    Aug 27, 2024 12:00 ET

  • Summary of Fosun Pharmaceutical\'s 2024 Semi-Annual Report

    Aug 27, 2024 12:00 ET

  • Fosun Pharmaceuticals 2024 First Quarter Report

    Apr 29, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Guangdong Hongjing Optoelectronic Technology Inc.
    301479
    153.13 +265.47%
    LTECH
    832110
    51.10 +28.78%
    HENDERA
    831152
    27.56 +20.40%
    JiangSu Jinji Industrial
    300798
    9.58 +20.05%
    Hynar Water Group
    300961
    20.69 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 18, 2025

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Innovative Drugs
    Innovative Drugs
    Intraday+1.92%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday+1.29%
    Private Hospitals
    Private Hospitals
    Intraday+0.90%